BRENT L LARSON

CIK 1195766 · EVP, CFO, Treas & Sec'y · last filed 2016-02-29

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

29

Lifetime Open-Market Net

-$309.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted EVP, CFO, Treas & Sec'y 320,318 $0.00 $32 -$275.0K 21 2016-02-29
NAVIDEA BIOPHARMACEUTICALS, INC. (NEOP) Delisted SVP, CFO, Treas & Secy 316,457 -$34.4K 1 2011-11-02

Recent Filings · Page 3 of 3

29 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-01-20 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Tax (F) −47,287 -$134.3K EDGAR
2011-11-02 NAVIDEA BIOPHARMACEUTICALS, INC. (NEOP) Delisted Mixed +65,676 -$122.7K EDGAR
2010-12-22 Grant (A) $0
2010-12-16 Mixed +31,620 -$31.3K
2009-11-03 Grant (A) $0
2009-10-23 Mixed +23,292 -$14.0K
2009-01-07 Grant (A) $0
2008-01-07 Grant (A) $0
2007-01-17 Grant (A) $0
Showing 2129 of 29
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.